The biology of IgE and the basis of allergic disease

Annual Review of Immunology

Volumn 21, Issue , 2003, Pages 579-628

  Gould, Hannah J ^a   Sutton, Brian J ^a   Beavil, Andrew J ^a   Beavil, Rebecca L ^a   McCloskey, Natalie ^a   Coker, Heather A ^a   Fear, David ^a   Smurthwaite, Lyn ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Allergy; IgE; IgE receptors; Immediate hypersensitivity; Mucosal immunity

Indexed keywords

CHYMASE; EOTAXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A2; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; LEUKOTRIENE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROSTAGLANDIN; RANTES; SEROTONIN; TRYPTASE; ALLERGEN; FC RECEPTOR; IMMUNOGLOBULIN E RECEPTOR;

ACUTE PHASE RESPONSE; ALLERGIC DISEASE; ALLERGIC REACTION; ALLERGY TEST; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CRYSTAL STRUCTURE; DENDRITIC CELL; ELECTRON MICROSCOPY; ENERGY TRANSFER; EOSINOPHIL; FEEDBACK SYSTEM; GENE STRUCTURE; GENETIC TRANSCRIPTION; GENOTYPE ENVIRONMENT INTERACTION; GERMINAL CENTER; HELPER CELL; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN CONSTANT REGION; IMMUNOGLOBULIN PRODUCTION; IMMUNOGLOBULIN STRUCTURE; MAST CELL; MAST CELL DEGRANULATION; MONOCYTE; MUCOSAL IMMUNITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROVOCATION TEST; RADIATION SCATTERING; RECEPTOR AFFINITY; RESPIRATORY TRACT MUCOSA; REVIEW; SCHISTOSOMIASIS; SOMATIC HYPERMUTATION; THERMODYNAMICS; THROMBOCYTE ACTIVATION; AMINO ACID SEQUENCE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; GENE REARRANGEMENT; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; NUCLEAR MAGNETIC RESONANCE; THROMBOCYTE; X RAY CRYSTALLOGRAPHY;

ALLERGENS; AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; BLOOD PLATELETS; CRYSTALLOGRAPHY, X-RAY; DISEASE MODELS, ANIMAL; EOSINOPHILS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN E; MODELS, MOLECULAR; MONOCYTES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; RECEPTORS, IGE; RECEPTORS, IGG; SCHISTOSOMIASIS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0038152342     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.21.120601.141103     Document Type: Review

References (288)

1. Sutton BJ, Gould HJ. 1993. The human IgE network. Nature 366:421-28
2. Metcalfe DD, Baram D, Mekori YA. 1997. Mast cells. Physiol. Rev. 77:1033-79
3. Galli SJ, Lantz CS. 1999. Allergy. See Ref. 280, pp. 1127-1174
4. Williams AF, Barclay AN. 1988. The immunoglobulin superfamily - domains for cell surface recognition. Annu. Rev. Immunol. 6:381-405
5. Lio A, Waldmann TA, Strober W. 1978. Metabolic study of human IgE: evidence for an extravascular catabolic pathway. J. Immunol. 20:1696-701
6. Lanzavecchia A, Parodi B. 1984. In vitro stimulation of IgE production at a single precursor level by human alloreactive T helper clones. Clin. Exp. Immunol. 55:197-203
7. King CL, Poindexter RW, Ragunathan J, Fleisher TA, Ottesen EA, Nutman TB. 1991. Frequency analysis of IgE-secreting B lymphocytes in persons with normal or elevated serum IgE levels. J. Immunol. 146:1478-83
8. Patterson R, Suszko IM, Hsu CC, Roberts M, Oh SH. 1975. In vitro production of IgE by lymphocytes from a patient with hyperimmunoglobulinaemia E, eosinophilia and increased lymphocytes carrying surface IgE. Clin. Exp. Immunol. 20:265-72
9. Smurthwaite L, Durham SR. 2002. Local IgE production in allergic rhinitis and asthma. Curr. Allergy Asthma Rep. 2:231-38
10. Gauld SB, Dal Porto JM, Cambier JC. 2002. B cell antigen receptor signaling: roles in cell development and disease. Science 296:1641-42
11. Ravetch JV, Kinet J-P. 1991. Fc receptors. Annu. Rev. Immunol. 9:457-92
12. Daëron M. 1997. Fc receptor biology. Annu. Rev. Immunol. 15:203-34
13. Gould HJ, Beavil RL, Reljić R, Shi J, Ma CW, et al. 1997. IgE homeostasis: Is CD23 the safety switch? See Ref. 281, pp. 37-59
14. Weis WI, Taylor ME, Drickamer K. 1998. The C-type lectin superfamily in the immune system. Immunol. Rev. 163:19-34
15. Padlan EA, Helm BA. 1993. Modelling of the lectin-homology domains of the human and murine low-affinity Fcε receptor (FcεRII//CD23). Receptor 3:325-41
16. Bajorath J, Aruffo A. 1996. Structure-based modeling of the ligand binding domain of the human cell surface receptor CD23 and comparison of two independently derived molecular models. Protein Sci. 5:240-47
17. Dierks SE, Bartlett WC, Edmeades RL, Gould HJ, Rao M, Conrad DH. 1993. The oligomeric nature of the murine FcγεRII/CD23: implications for function. J. Immunol. 150:2372-82
18. Kilmon MA, Ghirlando R, Strub M-P, Beavil RL, Gould HJ, Conrad DH. 2001. Regulation of IgE production requires oligomerization of CD23. J. Immunol. 167:3139-45
19. Szakonyi G, Guthridge JM, Li D, Young K, Holers VM, Chen XS. 2001. Structure of complement receptor 2 in complex with C3d ligand. Science 292:1725-28
20. Zheng Y, Shopes B, Holowka D, Baird B. 1991. Conformations of IgE bound to its receptor FcεRI and in solution. Biochemistry 30:9125-32
21. Deisenhofer J. 1981. Crysallographic refinement and atomic model of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9 and 2.8 Å resolution Biochemistry 20:2361-70
22. Beavil AJ, Young R, Sutton BJ, Perkins SJ. 1995. Bent domain structure of recombinant human IgE-Fc fragment by X-ray and neutron scattering in conjunction with an automated curve fitting procedure. Biochemistry 34:14449-61
23. Zheng Y, Shopes B, Holowka D, Baird B. 1992. Dynamic conformations compared for IgE and IgG1 in solution and bound to receptors. Biochemistry 31:7446-56
24. Feinstein A, Richardson N, Taussig MJ. 1986. Immunoglobulin flexibility in complement activation. Immunol. Today 7:169-74
25. Perkins SJ, Nealis AS, Sutton BJ, Feinstein A. 1991. Solution structure of human and mouse immunoglobulin M by synchrotron X-ray scattering and molecular graphic modelling. J. Mol. Biol. 221:1345-66
26. Keown MB, Ghirlando R, Mackay GA, Sutton BJ, Gould HJ. 1997. Basis of the 1:1 stoichiometry of the high affinity receptor FcεRI-IgE complex. Eur. Biophys. J. 25:471-76
27. Maenaka K, van der Merwe PA, Stuart DL, Jones EY, Sonderman PJ. 2001. The human low affinity Fcγ receptors IIa, IIb, and III bind IgG with fast kinetics and distinct thermodynamic properties. J. Biol. Chem. 276:44898-904
28. McDonnell JM, Calvert R, Beavil RL, Beavil AJ, Henry AJ, et al. 2001. The structure of the IgE Cε2 domain and its role in stabilizing the complex with its high-affinity receptor FcεRIα. Nat. Struct. Biol. 8:437-41
29. Ishizaka K, Ishizaka T. 1971. Immunoglobulin E and homocytotropic properties. In: Progress in Immunology I, ed. B. Amos, pp. 859-74. New York: Academic
30. Geha RS, Helm B, Gould H. 1985. Inhibition of the Prausnitz-Küstner reaction by an immunoglobulin e-chain synthesized in E. coli. Nature 315:577-78
31. Shi J, Ghirlando R, Beavil RL, Beavil AL, Keown MB, et al. 1997. Interaction of the low affinity receptor CD23/FcεRII lectin domain (sCD23) with the Fcε3-4 fragment of IgE. Biochemistry 36:2112-22
32. Wurzburg BA, Garman SC, Jardetzky TS. 2000. Structure of the human Cε3-Cε4 reveals conformational flexibility in the antibody effector domains. Immunity 13:375-85
33. Padlan EA, Davies DR. 1986. A model of the Fc of immunoglobulin E. Mol. Immunol. 23:1063-75
34. Helm BA, Ling Y, Teale C, Padlan EA, Bruggemann M. 1991. The nature and importance of the inter-epsilon chain disulfide bonds in human IgE. Eur. J. Immunol. 21:1543-48
35. Garman SC, Kinet J-P, Jardetzky TS. 1999. The crystal structure of the human high-affinity IgE receptor (FcεRIα). Annu. Rev. Immunol. 17:973-76
36. Garman SC, Kinet J-P, Jardetzky TS. 1998. Crystal structure of the human high-affinity IgE receptor. Cell 95:951-61
37. Garman SC, Sechi S, Kinet J-P, Jardetzky TS. 2001. The analysis of the human high affinity IgE receptor FcεRIα from multiple crystal forms. J. Mol. Biol. 311:1049-62
38. Garman SC, Wurzburg BA, Tarchevskaya SS, Kinet J-P, Jardetzky TS. 2000. Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα. Nature 406:259-66
39. Maxwell KF, Powell MS, Hulett MD, Barton PA, McKenzie IF, et al. 1999. Crystal structure of the human leukocyte Fc receptor, FcγRIIα. Nat. Struct. Biol. 6:437-42
40. Sondermann P, Huber R, Jacob U. 1999. Crystal structure of the soluble form of the human FcγRIIβ: a new member of the immunoglobulin superfamily at 1.7A resolution. EMBO J. 18:1095-103
41. Zhang Y, Boesen CC, Radaev S, Brooks AG, Fridman WH, et al. 2000. Crystal structure of the extracellular domain of a human FcγRIII. Immunity 13:387-95
42. Sondermann P, Huber R, Oosthuizen V, Jacob U. 2000. The 3.2 Å-crystal structure of the human IgG1 Fc fragment-FcγRIII complex. Nature 406:267-73
43. Radaev S, Sun PD. 2001. Recognition of IgG by Fcγ receptor. The role of Fc glycosylation and the binding of peptide inhibitors. J. Biol. Chem. 276:16478-83
44. Radaev S, Motyka S, Fridman W-H, Sautes-Fridman C, Sun PD. 2001. The structure of a human type III Fcγ receptor in complex with Fc. J. Biol. Chem. 276:16469-77
45. Wurzburg BA, Jardetzky TS. 2002. Structural insights into the interactions between human IgE and its high affinity receptor FcεRI. Mol. Immunol. 38:1063-72
46. Wan T, Beavil RL, Fabiane SM, Beavil AJ, Sohi MK, et al. 2002. Crystal structure of IgE Fc reveals an asymmetrically bent conformation. Nat. Immunol. 3:681-85
47. Sayers I, Cain SA, Swan JRM, Pickett MA, Watt PJ, et al. 1998. Amino acid residues that influence FcεRI-mediated effector functions of human immunoglobulin E. Biochemistry 37:16152-64
48. Henry AJ, Cook JPD, McDonnell JM, Mackay GA, Shi J, et al. 1997. Participation of the N-terminal region of Cε3 in the binding of the human IgE to its high-affinity receptor FcεRI. Biochemistry 361:5568-78
49. Cook JPD, Henry AJ, McDonnell JM, Owens RJ, Sutton BJ, Gould HJ. 1997. Identification of contact residues in the IgE binding site of human FcεRIα. Biochemistry 36:15579-88
50. Sutton B, Corper A, Bonagura V, Taussig M. 2000. The structure and origin of rheumatoid factors. Immunol. Today 21:177-83
51. Pawankar R, Okuda M, Yssel H, Okumura K, Ra C. 1997. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FcεRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J. Clin. Invest. 99:1492-99
52. Wedemeyer J, Galli SJ. 2000. Mast cells and basophils in acquired immunity. Br. Med. Bull. 56:936-55
53. Wedermeyer J, Tsai M, Galli SJ. 2000. Roles of mast cells and basophils in innate and acquired immunity. Curr. Opin. Immunol. 12:624-31
54. Kay AB. 1997. Allergy and Allergic Diseases. Oxford: Blackwell Sci.
55. Holgate ST, Church MK, Lichtenstein LM. 2001. Allergy. St. Louis, MO: Mosby
56. Gauchat J-F, Henchoz S, Mazzei G, Aubry J-P, Brunner T, et al. 1993. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365:340-43
57. Humbert M, Grant JA, Taborda-Barata L, Durham SR, Pfister R, et al. 1996. High-affinity IgE receptor (FcεRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am. J. Respir. Crit. Care Med. 153:1931-37
58. Hsu C, McGlashan DW Jr. 1996. IgE antibody up-regulates high affinity IgE binding on murine bone marrow-derived mast cells. Immunol. Lett. 52:129-34
59. Toru H, Ra C, Nonoyama S, Suzuki K, Yata J-I, Nakahata T. 1996. Induction of the high-affinity receptor (FcεRI) on human mast cells by IL4. Int. Immunol. 8:1367-73
60. Yano K, Yamaguchi M, de Mora F, Lantz CS, Butterfield JH, et al. 1997. Production of macrophage inflammatory protein-1α by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability. Lab. Invest. 77:185-93
61. MacGlashan DW Jr, Bochner BS, Adelman DC, Jardieu PM, Toglas A, et al. 1997. Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE. J. Immunol. 158:1438-45
62. MacGlashan DW Jr, Bochner BS, Adelman DC, Jardieu PM, Toglas A, Lichtenstein LM. 1997. Serum IgE level drives basophil and mast cell IgE receptor display. Int. Arch. Allergy Immunol. 113:45-47
63. Lantz CS, Yamaguchi M, Oettgen HC, Katona IM, Miyajama I, et al. 1997. IgE regulates mouse basophil FcεRI expression in vivo. J. Immunol. 158:2517-21
64. Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, et al. 1997. IgE enhances mouse mast cell FcεRI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE reactions. J. Exp. Med. 185:663-72
65. Sihra BS, Kon OM, Grant JA, Kay AB. 1997. Expression of high-affinity IgE receptors (FcεRI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations. J. Allergy Clin. Immunol. 99:699-706
66. MacGlashan DW Jr, McKenzie-White J, Chichester K, Bochner BS, Davis FM, et al. 1998. In vitro regulation of FcεRIα expression on human basophils by IgE antibody. Blood 91:1633-43
67. MacGlashan DW Jr, Lichtenstein LM, MacKenzie-White J, Chichester K, Henry AJ, et al. 1999. Upregulation of FcεRI on human basophils by IgE antibody is mediated by the interaction of IgE with FcεRI. J. Allergy Clin. Immunol. 104:492-508
68. Yamaguchi M, Sayama K, Yano K, Lantz CS, Noben-Trauth N, et al. 1999. IgE enhances Fcε receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fcε receptor I expression and mediator release. J. Immunol. 162:5455-65
69. Saini SS, Klion AD, Holland SM, Hamilton RG, Bochner BS, MacGlashan DW Jr. 2000. The relationship between serum IgE and surface levels of FcεRI on human leukocytes in various diseases: correlation of expression with FcεRI on basophils but not on monocytes or eosinophils. J. Allergy Clin. Immunol. 2000:106:514-20
70. MacGlashan D Jr, Schroeder JT. 2000. Functional consequences of FcεRI up-regulation by IgE in human basophils. J. Leukoc. Biol. 68:479-86
71. Borkowski TA, Jouvain M-H, Lin S-Y, Kinet J-P. 2001. Minimal requirements for IgE-mediated regulation of surface FcεRI. J. Immunol. 167:1290-96
72. Katoh N, Kraft S, Wessendorf JHM, Bieber T. 2000. The high-affinity IgE receptor (FcεRI) blocks apoptosis in normal human monoytes. J. Clin. Invest. 105:183-90
73. Asai K, Kitaura J, Kawakami Y, Yamagata N, Tsai M, et al. 2001. Regulation of mast cell survival by IgE. Immunity 14:791-800
74. Kalesnikoff J, Huber M, Lam V, Damen JE, Zhang J, et al. 2001. Monomeric IgE stimulates signalling pathways in mast cells that lead to cytokine production and cell survival. Immunity 14:801-11
75. Kawakami T, Galli SJ. 2002. Regulation of mast cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2:773-86
76. Dombrowicz D, Flamand V, Miyajima I, Ravetch JV, Galli SJ, Kinet J-P. 1997. Absence of FcεRIα chain results in up-regulation of FcγRIII -dependent mast cell degranulation and anaphylaxis: evidence of competition between FcεRI and FcγRIII for limiting amounts of FcRβ and g chains. J. Clin. Invest. 99:915-25
77. Kinet J-P. 1999. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annu. Rev. Immunol. 17:931-72
78. Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet J-P, Galli SJ. 1997. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII. J. Clin. Invest. 99:901-14
79. Strait RT, Morris SC, Yang M, Qu X-W, Finkelman FD. 2002. Pathways of anaphylaxis in the mouse. J. Allergy Clin. Immunol. 109:658-68
80. Bartlett WC, Graber P, Bonnefoy J-Y, Ahearn JM, Conrad DH. 1993. Evidence for lack of species specificity for the CD23-CD21 interaction. J. Immunol. 150:A223 (Abstr.)
81. Lack G, Renz H, Saloga J, Brandley KL, Loader J, et al. 1994. Nebulized but not parenteral IFN-γ decreases IgE prodution and normalizes airway function in a murine model of allergen sensitization J. Immunol. 152:2546-54
82. Renz H, Enssle K, Lauffer L, Kurrle R, Gelfand EW. 1995. Inhibition of allergen-induced IgE and IgG1 production by soluble IL-4 receptor. Int. Arch. Allergy Immunol. 106:46-54
83. Hamelmann E, Oshiba A, Loader J, Larsen GL, Gleich G, et al. 1997. Interleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitisation. Am. J. Respir. Crit. Care Med. 155:819-25
84. Dombrowicz D, Brini AT, Flamnd V, Hicks E, Snouwaert JKN, et al. 1996. Anaphylaxis mediated through a humanized high affinity IgE receptor. J. Immunol. 157:1645-51
85. Fung-Leung W-P, De Sousa-Hitzler J, Ishaque A, Zhou L, Pang J, et al. 1996. Transgenic mice expressing the human high-affinity immunoglobulin (Ig) E receptor a-chain respond to human IgE in mast cell degranulation and in allergic reactions. J. Exp. Med. 183:49-56
86. Dombrowicz D, Nutten S, Desreumaux P, Neut C, Torpier G, et al. 2001. Role of the high affinity immunoglobulin E receptor in bacterial translocation and intestinal inflammation. J. Exp. Med. 193:25-34
87. Dombrowicz D, Quatannens B, Papin J-P, Capron A, Capron M. 2000. Expression of a functional FcεRI on rat eosinophils and macrophages. J. Immunol. 165:1266-71
88. Wardlaw AJ, Brightling C, Green R, Woltmann G, Pavord I. 2000. Eosinophils in asthma and other allergic diseases. Br. Med. Bull. 56:985-1003
89. Kita H, Kaneko M, Bartemes KR, Weiler DA, Schimming AW, et al. 1999. Does IgE bind to and activate eosinophils from patients with allergy? J. Immunol. 162:6901-11
90. Seminario M-C, Saini SS, MacGlashan DW Jr, Bochner BS. 1999. Intracellular expression and release of FcεRIα by human eosinophils. J. Immunol. 162:6893-900
91. Kayaba H, Dombrowicz D, Woerly G, Papin J-P, Loiseau S, Capron M. 2001. Human eosinophils and human high affinity IgE receptor transgenic mouse eosinophils express low levels of high affinity IgE receptor, but release IL-10 upon receptor activation. J. Immunol. 167:995-1003
92. Gounni AS, Lamkhloued B, Ochial K, Yanaka Y, Delaporte E, et al. 1994. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 367:183-86
93. Joseph M, Gounni AS, Vorng H, Sarfati M, Kinet J-P, et al. 1997. Expression and functions of the high-affinity IgE receptor on human platelets and megakaryocyte precursors. Eur. J. Immunol. 27:2212-18
94. Dombrowicz D, Capron M. 2001. Eosinophils, allergy and parasites. Curr. Opin. Immunol. 13:716-20
95. Karagiannis S, Wang Q, East N, Burke F, Riffard S, et al. 2003. Activity of human monocytes and basophils in surveillance and killing of ovarian tumor cells. Submitted
96. Grant JA, Humbert M, Taborada-Barata L, Sihra BS, Kon OM, et al. 1997. High-affinity IgE receptor FcεRI expression in allergic reactions. Int. Arch. Allergy Immunol. 113:376-78
97. Maurer D, Fiebiger E, Ebner C, Reininger B, Fischer GF, et al. 1996. Peripheral blood dendritic cells express FcεRI as a complex composed of FcεRIα and FcεRI γ-chains and can use this receptor for IgE-mediated allergen presentation. J. Immunol. 157:607-16
98. Maurer D, Fiebiger E, Reininger B, Wolff-Winiski B, Jouvin M-H, et al. 1994. Expression of functional high affinity immunoglobulin E receptors (FcεRI) on monocytes of atopic individuals. J. Exp. Med. 179:745-50
99. Reischl IG, Dubois GR, Peiritsch S, Brown KS, Wheat L, et al. 2000. Regulation of FcεRI expression on human monocytic cells by ligand and IL-4. Clin. Exp. Allergy 30:1033-40
100. Geiger E, Magerstaedt R, Wessendorf JHM, Kraft S, Hanau D, Bieber T. 2000. IL-4 induces the intracellular expression of the a chain of the high-affinity receptor for IgE in in vitro-generated dendritic cells. J. Allergy Clin. Immunol. 105:150-56
101. Bjerke T, Hoffmann HJ, Christensen EI, Poulsen LK, Skjold T, Dahl R. 1999. Regulation of FcεRI synthesis in human eosinophils. Int. Arch. Allergy Immunol. 118:440-42
102. Terada N, Konnon A, Terada Y, Fukuda S, Yamashita T, et al. 1995. IL-4 upregulates FcεRI α-chain messenger RNA in eosinophils. J. Allergy Clin. Immunol. 96:1161-69
103. Lin S, Cicala C, Scharenberg AM, Kinet J-P. 1996. The FcRIβ subunit functions as an amplifier of FcεRIγ-mediated cell activation signals. Cell 85:985-95
104. Donnadieu E, Jouvin M-H, Kinet J-P. 2000. A second amplifier function for the allergy-associated FcεRI-β subunit. Immunity 12:515-23
105. Capron M, Capron A. 1994. Immunoglobulin E and effector cells in schistosomiasis. Science 264:1876-77
106. Verwaerde C, Joseph M, Capron M, Pierce RJ, Damonneville M, et al. 1987. Functional properties of a rat monoclonal IgE antibody specific for Schistosoma mansoni. J. Immunol. 138:4441-46
107. Capron A, Dombrowicz D, Capron M. 1999. Regulation of the immune response in experimental and human schistosomiasis: the limits of an attractive paradigm. Microbes Infect. 1:485-90
108. King CL, Xianli J, Malhotra I, Liu S, Mahmoud AAF, Oettgen HC. 1997. Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni. J. Immunol. 158:294-300
109. Jankovic D, Kullberg MC, Dombrowicz D, Barbieri S, Caspar P, et al. 1997. FcεRI-deficient mice infected with Schistosoma mansoni mount normal Th2-type responses while displaying enhanced liver pathology. J. Immunol. 159:1868-75
110. Finkelman FD, Shea-Donohue T, Goldhill J, Sullivan CA, Morris SC, et al. 1997. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: Lesson from studies with rodent models. Annu. Rev. Immunol. 15:505-33
111. Urban JF Jr, Noben-Trauth N, Donalson DD, Madden KB, Morris SC, et al. 1998. IL-13, IL-4α and Stat6 are reqired for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 8:255-64
112. Frandji P, Tzaczyk C, Oskéritzian C, Lapeyre J, Peronet R, et al. 1995. Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon γ. Cell. Immunol. 163:37-46
113. Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF. 2000. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J. Clin. Invest. 105:945-53
114. Maurer D, Ebner C, Reininger B, Fiebiger E, Kraft D, et al. 1995. The high-affinity IgE receptor (FcεRI) mediates IgE-dependent allergen presentation. J. Immunol. 154:6285-90
115. Stingl G, Maurer D. 1997. IgE-mediated allergen presentation via FcεRI on antigen-presenting cells. Int. Arch. Allergy Immunol. 113:24-29
116. Bieber T. 1997. FcεRI-expressing antigen-presenting cells: new players in the atopic game. Immunol. Today 18:311-13
117. Mudde GC, Bheekha R, Bruijnzeel-Koomen CA. 1995. Consequences of IgE/CD23-mediated antigen presentation in allergy. Immunol. Today 16:380-83
118. Marolewski AE, Buckle DR, Christie G, Earnshaw DL, Flamberg PL, et al. 1998. CD23 (FcεRII) release from cell membranes is mediated by a membrane-bound metalloprotease. Biochem. J. 333:573-79
119. Schulz O, Sutton BJ, Beavil RL, Shi J, Sewell HF, et al. 1997. Cleavage of the low-affinity receptor for human IgE (CD23) by a mite cysteine protease: nature of the cleaved fragment in relation to the structure and function of CD23. Eur. J. Immunol. 27:584-88
120. Bonnefoy J-Y, Gauchat J-F, Lecoanet-Henchoz S, Graber P, Aubry J-P. 1996. Regulation of human IgE synthesis. Ann. NY Acad. Sci. 796:59-71
121. van der Heijden FL, van Neerven RJJ, van Katwijk M, Bos JD, Kapsenberg ML. 1993. Serum IgE-facilitated allergen presentation in atopic disease. J. Immunol. 150:3643-50
122. Santamaria LF, Bheekha R, van Reijsen EC, Perez Soler MT, Suter M, et al. 1993. Antigen focusing by specific monomeric immunoglobulin E bound to CD23 on Epstein-Barr virus-transformed B cells. Hum. Immunol. 37:23-30
123. Karagiannis SN, Warrack JK, Jennings KH, Murdock PR, Christie G, et al. 2001. Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells. Immunology 103:319-31
124. + T lymphocytes and CD21 on B lymphocytes in patients with allergic asthma: evidence and regulation. Eur. J. Immunol. 24:1109-14
125. + T cell clones. Eur. J. Immunol. 24:2982-86
126. Lamers MC, Yu P. 1995. Regulation of IgE synthesis: lessons from the study of IgE transgenic and CD23-deficient mice. Immunol. Rev. 148:71-95
127. Payet M, Conrad DH. 1999. IgE regulation of CD23 knockout and transgenic mice. Allergy 54:1125-29
128. Däeron M, Malbec O, Latour S, Arock M, Fridman WH. 1995. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J. Clin. Invest. 95:577-85
129. Ujike A, Ishikawa Y, Ono M, Yuasa T, Yoshino T, et al. 1999. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affiniy Fc receptors for IgG. J. Exp. Med. 189:1573-77
130. Yang P-C, Berin M, Yu LCH, Conrad DH, Perdue MH. 2000. Enhanced intestinal transepithelial antigen transport in allergic rats is mediated by IgE and CD23 (FcεRII). J. Clin. Invest. 106:879-86
131. Kaiserlian D, Lachaux A, Grosjean I, Graber P, Bonnefoy J-Y. 1993. Intestinal epithelial cells express the CD23/FcεRII molecule: enhanced expression in enteropathies. Immunology 80:90-95
132. Tew JG, Wu J, Fakhar M, Szakal AK, Qin D. 2001. Follicular dendritic cells: beyond the necessity of T-cell help. Trends Immunol. 22:361-67
133. Liu Y-J, Cairns JA, Holder MJ, Abbot SD, Jansen KU, et al. 1991. Recombinant 25 kDa CD23 and interleukin-1 promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur. J. Immunol. 21:1107-14
134. Bonnefoy J-Y, Henchoz S, Hardie D, Holder MJ, Gordon J. 1993. A subset of anti-CD21 antibodies promote the rescue of germinal center B cells from apoptosis. Eur. J. Immunol. 23:969-72
135. Reljić R, Cosentino G, Gould JH. 1997. Function of CD23 in the response of human B cells to antigen. Eur. J. Immunol. 27:572-75
136. Deleted in proof
137. Aubry JP, Pochon S, Graber P, Jansen K, Bonnefoy J-Y. 1992. CD21 is a ligand for CD23 and regulates IgE production. Nature 358:505-7
138. Pène J, Rousset F, Brière F, Chrétien, Wideman J, et al. 1988. Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen. Eur. J. Immunol. 18:929-35
139. Ma C. 2003. Functional studies of CD23. PhD thesis. Univ. London
140. Max EE. 1999. Immunoglobulins: molecular genetics. See Ref. 280, pp. 11-182
141. Deleted in proof
142. Deleted in proof
143. Warr GW, Magor KE, Higgins DA. 1995. IgY: clues to the origins of modern antibodies. Immunol. Today 16:392-98
144. Paul WE. 1999. The immune system: an introduction. See Ref. 280, pp. 1-35
145. Romagnani S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227-57
146. Abbas AK, Murphy KM, Sher A. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-93
147. Romagnani S. 2000. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85:9-18
148. Romagnani S. 2001. T-cell responses in allergy and asthma. Curr. Opin. Allergy Clin. Immunol. 1:73-78
149. Liew FY. 2002. Th1 and Th2 cells: a historical perspective. Nat. Rev. Immunol. 2:55-60
150. Neurath MF, Sinotto S, Glimcher LH. 2002. The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 8:567-73
151. O'Shea JJ, Paul WE. 2002. Regulation of TH1 differentiation - controlling the controllers. Nat. Immunol. 3:506-8
152. Gett AV, Hodgkin PD. 1998. Cell division regulates the T cell cytokine repertoire, revealing the mechanism underlying immune class regulation. Proc. Natl. Acad. Sci. USA 95:9488-93
153. Bird JJ, Brown DR, Mjullen AC, Moskowitz NH, Mahowald MA, et al. 1998. Helper T cell differentiation is controlled by the cell cycle. Immunity 9:229-37
154. Coffman RL, Reiner SL. 1999. Instruction, selection, or tampering with the odds. Science 284:1283-85
155. O'Garra A, Arai N. 2000. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 10:542-50
156. Avni O, Rao A. 2000. T cell differentiation: a mechanistic view. Curr. Opin. Immunol. 12:654-59
157. Takemoto N, Kamogawa Y, Lee HJ, Kurata H, Arai KI, et al. 2000. Chromatin remodeling at the IL-4/IL-13 intergenic regulatory region for Th2-specific gene cluster. J. Immunol. 165:6687-91
158. Avni O, Lee D, Macian F, Szabo SJ, Glimcher LH, Rao A. 2002. T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat. Immunol. 3:643-51
159. Fitch FW, McKisick MD, Lancki DW, Gajewski TF. 1993. Differential regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 11:29-48
160. Mason D. 1996. The role of B cells in the programming oft cells for IL-4 synthesis. J. Exp. Med. 183:717-19
161. Stockinger B, Zal T, Zal A, Gray D. 1996. B cells solicit their own help from T cells. J. Exp. Med. 183:891-99
162. + cells. Adv. Immunol. 53:1-29
163. Seder RA, Paul WE, Dvorak AM, Sharkis SJ, Kagey-Sobotka A, et al. 1991. Mouse splenic and bone marrow cell populations that express high-affinity Fcε receptors and produce IL-4 are high enriched in basophils. Proc. Natl. Acad. Sci. USA 88:2835-39
164. Lambrecht BN. 2001. The dendritic cell in allergic airway diseases: a new player to the game. Clin. Exp. Allergy 31:206-18
165. De Jong EC, Viera PL, Kalinski P, Schuitemaker JHN, Tanaka Y, et al. 2002. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals. J. Immunol. 168:1704-9
166. Van der Kleij D, Van Remoortere A, Schuitemaker JHN, Kapsenberg ML, Deelder AM, et al. 2002. Triggering of innate immune responses by schistosome egg glycolipids and their carbohydrate epitope GalNAcβ1-4(Fucα 1-3)GlcNAc. J. Infect. Dis. 185:531-39
167. DeSmedt T, Van Mechelen M, DeBecker C, Urbain J, Leo O, Moser M. 1997. Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27:1229-35
168. Kalinski P, Hilkens CMU, Snijders A, Kapsenberg ML. 1997. IL-12 deficient dendritic cells, generated in the presence of prostaglandin E2, promote Type 2 cytokine production in maturing human naïve T helper cells. J. Immunol. 159:28-35
169. Stumbles PA, Thomas JA, Pumm CL, Lee PT, Venoulle TJ, et al. 1998. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J. Exp. Med. 188:2019-2031
170. + T cell response: the alternative approaches. Annu. Rev. Immunol. 15:297-322
171. Rogers PR, Croft M. 1999. Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 balance. J. Immunol. 163:1205-13
172. Kalinski P, Hilkens CMU, Wierenga EA, Kapsenberg ML. 1999. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20:561-67
173. Comoy E, Pestel J, Stewart GA, Finkelman F, Capron A, Thyphronitis G. 1999. Do allergens induce type-2 immune responses? Int. Arch. Allergy Immunol. 119:399-402
174. Deleted in proof
175. Iwasaki A, Kelsall BL. 1999. Freshly isolated Peyer's patch but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 190:229-39
176. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, et al. 1999. The nature of the principal type I interferon-producing cells in human blood. Science 284:1835-37
177. Cough L, Schulz O, Sewell HF, Shakib F. 1999. The cysteine protease activity of the major dust mite allergen Der p 1 selectively enhances the immunoglobulin E antibody response. J. Exp. Med. 190:1897-901
178. Ghaemmaghami AM, Robins RA, Cough L, Sewell HF, Shakib F. 2001. Human T cell subset commitment determined by the intrinsic property of antigen: The proteolytic activity of the major mite allergen Der p conditions T cells to produce more IL-4 and less IFN-g. Eur. J. Immunol. 31:1211-16
179. Ghaemmaghami AM, Shakib F. 2002. Human T cells that have been conditioned by the proteolytic activity of the major dust mite allergen Der p 1 trigger enhanced immunoglobulin E synthesis in B cells. Clin. Exp. Allergy 32:728-32
180. Deleted in proof
181. Shakib F, Schulz O, Sewell H. 1998. A mite subversive: cleavage of CD23 and CD25 by Der p 1 enhances allergenicity. Immunol. Today 7:313-16
182. Duffy DL, Martin NG, Battistutta D, Hopper JL, Mathews JD. 1990. Genetics of asthma and hay fever in Australian twins. Am. Rev. Respir. Dis. 142:1351-58
183. Ono SJ. 2000. Molecular genetics of allergic disease. Annu. Rev. Immunol. 18:347-66
184. Patiño CM, Martinez FD. 2001. Interactions between genes and environment in the development of asthma. Allergy 56:279-86
185. Rosenwasser LJ. 1997. Genetics of atopy and asthma: promoter-based candidate gene studies for IL-4. Int. Arch. Allergy Immunol. 113:61-64
186. Vercelli D, Baldini M, Martinez F. 2001. The monocyte/IgE connection; may polymorphisms in the CD14 gene teach us about IgE regulation? Int. Arch. Allergy Immunol. 124:20-24
187. Vercelli D, Baldini M, Stern D, Lohman IC, Halonen M, Martinez F. 2001. CD14: a bridge between innate immunity and adaptive IgE responses. J. Endotoxin Res. 7:45-48
188. Gould HJ, Beavil RL, Vercelli D. 2000. IgE isotype determination: e-germline gene transcription, DNA recombination and B-cell differenation. Br. Med. Bull. 56:908-24
189. Gauchat J-F, Lebman DA, Coffman RL, Gascan H, de Vries JE. 1990. Structure and expression of germline ε transcripts in human B cells induced by interleukin 4 to switch to IgE production. J. Exp. Med. 172:463-73
190. Nelms K, Keegan AD, Zamarono J, Ryan JJ, Paul WE. 1999. The IL-4 receptor: signalling mechanisms and biological function. Annu. Rev. Immunol. 17:701-38
191. Jiang H, Harris MB, Rothman P. 2000. IL-4/IL-13 signaling beyond JAK/STAT. J. Allergy Clin. Immunol. 105:1063-70
192. Monticelli S, Vercelli D. 2001. Molecular regulation of class switch recombination to IgE through ε germline transcription. Allergy 56:270-78
193. Oettgen H. 2000. Regulation of the IgE isotype switch: new insights on cytokine signals and the functions of ε germline transcripts. Curr. Opin. Immunol. 12:618-23
194. Van Kooten C, Banchereau J. 1996. CD40-CD40 ligand: a multifunctional receptor. Adv. Immunol. 61:1-77
195. Karin M, Lin A. 2002. NF-κB at the crossroads of life and death. Nat. Immunol. 3:221-27
196. Schebesta M, Heavey B, Busslinger M. 2002. Transcriptional control of B-cell development. Curr. Opin. Immunol. 14:216-23
197. Monticelli S, Ghittoni R, Kabesch M, Vercelli D. 2001. Myb proteins repress human Ig ε germline transcription by inhibiting STAT6-dependent promoter activation. Mol. Immunol. 38:1129-38
198. Honjo T, Kinoshita K, Muramatsu M. 2002. Molecular mechanism of class switch recombination. Annu. Rev. Immunol. 20:165-96
199. Kinoshita K, Honjo T. 2000. Unique and unprecedented recombination mechanisms in class switching. Curr. Opin. Immunol. 12:195-98
200. Tashiro J, Kinoshita K, Honjo T. 2001. Palindromic but not G-rich sequences are targets of class switch recombination. Int. Immunol. 13:495-505
201. Mussmann R, Courtet M, Schwager J, Du Pasquier L. 1997. Microsites for immunoglobulin switch recombination breakpoints from Xenopus to mammals. Eur. J. Immunol. 27:2610-19
202. Tian M, Alt FW. 2000. Transcription induced cleavage of immunoglobulin switch. J. Biol. Chem. 275:24163-72
203. Ehrenstein MR, Rada C, Jones A-M, Milstein C, Neuberger MS. 2001. Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination. Proc. Natl. Acad. Sci. USA 98:14553-58
204. Hopfner K-P, Craig L, Moncalian G, Zinkel RA, Usui T, et al. 2002. The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination and repair. Nature 418:562-66
205. Paull TT, Rogaku EP, Yamazaki V, Kirschgessner CU, Gellert M, Bonner WM. 2000. A critical role for H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10:886-95
206. Petersen S, Casellas R, Reina-SanMartin B, Chen HT, Difilippantonio MJ, et al. 2001. AID is required to initiate Nbs1/γ-H2AX focus formation and mutations at sites of class switching. Nature 414:660-65
207. Zhou J, Ermakova OV, Riblet R, Birshtein BK, Schildkraut CL. 2002. Replication and subnuclear location dynamics of the immunoglobulin heavy-chain locus in B-lineage cells. Mol. Cell. Biol. 22:4876-89
208. Lundgren M, Ström L, Bergquist L-O, Skog S, Heiden T, et al. 1995. Cell cycle regulation of immunoglobulin class switch recombination and germline gene transcription: potential role of Ets family members. Eur. J. Immunol. 25:2042-51
209. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. 2000. Class switch recombination and hypermuation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102:553-63
210. Kinoshita K, Honjo T. 2001. Linking class-switch recombination with somatic hypermutation. Nat. Rev. Mol. Biol. 2:493-503
211. Martin A, Bardwell PD, Woo CJ, Fan M, Shulman MJ, Scharff MD. 2002. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature 415:802-6
212. Okazaki I, Kinoshita K, Muramatsu M, Yoshikawa K, Honjo T. 2002. The AID enzyme induces class switch recombination in fibroblasts. Nature 416:340-45
213. Chua KE, Alt FW, Manis JP. 2002. The function of AID in somatic mutation and class switch recombination: upstream or downstream of DNA breaks. J. Exp. Med. 195:F37-41
214. Wuerffel RA, Du J, Thompson RJ, Kenter AL. 1997. Ig Sγ3 DNA-specific double strand breaks are induced in mitogen-activated B cells and are implicated in switch recombination. J. Immunol. 159:4139-44
215. Petersen-Mahrt SK, Harris RS, Neuberger MS. 2002. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418:99-103
216. Hibi T, Dosch HM. 1986. Limiting dilution analysis of the B cell compartment in human bone marrow. Eur. J. Immunol. 16:139-45
217. Calame KL. 2001. Plasma cells: finding new light at the end of B cell development. Nat. Immunol. 2:1103-8
218. Calame K. 2003. Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21:205-230
219. Niu H, Ye BH, Dalla-Favera R. 1998. Antigen receptor signalling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev. 12:1953-61
220. Reljić R, Wagner SD, Peakman JL, Fearon DT. 2000. Suppression of signal transducer and activator of transcription-dependent B lymphocyte terminal differentiation by BCL-6. J. Exp. Med. 192:1841-48
221. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. 2000. BCL-6 represses genes that function in lymphocyte differentiation, inflammation and cell cycle control. Immunity 13:199-212
222. Jung J, Choe J, Li L, Choi YS. 2000. Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10. Eur. J. Immunol. 30:2437-43
223. Agematsu K, Hokibara S, Nagumo H, Komiyama A. 2000. CD27: a memory B-cell marker. Trends Immunol. 21:204-6
224. Nagumo H, Agematsu K, Shinozaki K, Hokibara S, Ito S, et al. 1998. CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells. J. Immunol. 161:6496-502
225. Randall TD, Heath AW, Santos-Argumedo L, Howard MC, Weissman IL, Lund FE. 1998. Arrest of B lymphocyte terminal differentiation by CD40 signalling mechanism for lack of antibody-secreting cells in germinal centers. Immunity 8:733-42
226. Lutzker S, Rothman P, Pollock R, Coffman R, Alt FW. 1988. Mitogen- and IL-4-regulated expression of germ-line Ig γ2b transcripts: evidence for directed heavy chain class switching. Cell 53:177-84
227. Rose SM, Garrard WT. 1984. Differentiation-dependent chromatin alterations precede and accompany transcription of immunoglobulin light chain genes. J. Biol. Chem. 259:8534-44
228. Fujieda S, Zhang K, Saxon A. 1995. IL-4 plus CD40 monoclonal antibody induces human B cells γ subclass-specific isotype switch: switching to γ 1, γ3, and γ4, but not γ2. J. Immunol. 155:2318-28
229. + B cell line. J. Immunol. 160:2145-57
230. Morse L, Chen D, Franklin D, Xiong Y, Chen-Kiang S. 1997. Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18INK4c and IL-6. Immunity 6:47-56
231. Jego G, Bataille R, Pellat-Deceunynck C. 2001. Interleukin-6 is a growth factor for non-malignant human plasmablasts. Blood 97:1817-22
232. Malisan F, Brière F, Bridon J-M, Harindranath N, Mills FC, et al. 1996. Interleukin-10 induced immunoglobulin G isotype switch recombination in human CD40-activated naïve B lymphocytes. J. Exp. Med. 183:937-47
233. Snapper CM, Marcu KB, Zelazowski P. 1997. The immunoglobulin class switch: beyond "accessibility." Immunity 6:217-23
234. Hasbold J, Lyons AB, Kehry MR, Hodgkin PD. 1998. Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4. Eur. J. Immunol. 28:1040-51
235. Deenick E, Hasbold J, Hodgkin PD. 1999. Switching to IgG3, IgG2b, and IgA is division linked and independent, revealing a stochastic framework for describing differentiation. J. Immunol. 163:4707-14
236. McCall MN, Hodgkin PD. 1999. Switch recombination and germ-line transcription are division-regulated events in B lymphocytes. Biochim. Biophys. Acta 1447:43-50
237. Rush JS, Hasbold J, Hodgkin PD. 2002. Cross-linking surface Ig delays CD40 ligand- and IL-4-induced class switching and reveals evidence for independent regulation of B cell proliferation and differentiation. J. Immunol. 168:2676-82
238. Yoshida K, Matsuoka M, Usuda S, Mori A, Ishizaki K, Sakno H. 1990. Immunoglobulin switch circular DNA in the mouse infected with Nippostrongylus brasiliensis: evidence for successive class switching from μ to ε via γ 1. Proc. Natl. Acad. Sci. USA 87:7829-33
239. Siebenkotten G, Esser C, Wabl M, Radbruch A. 1992. The murine IgG1/IgE class switch program. Eur. J. Immunol. 22:1827-34
240. Mandler R, Finkelman FD, Levine AD, Snapper CM. 1993. IL-4 induction of IgE class switching by lipopolysaccharide-activated murine B cells occurs predominantly through sequential switching. J. Immunol. 150:407-18
241. Mills FC, Thyphronitis G, Finkelman FD, Max EE. 1992. Ig μ-ε isotype switch in IL-4-treated human B lymphoblastoid cells: evidence for a sequential switch. J. Immunol. 149:1075-85
242. + T cell clones. J. Exp. Med. 173:747-50
243. Zhang K, Mills FC, Saxon A. 1994. Switch circles from IL-4-directed ε class switching from human B lymphocytes: evidence for direct, sequential, and multiple step sequential switch form μ to ε Ig heavy chain gene. J. Immunol. 152:3427-35
244. Mills FC, Mitchell MP, Hrindranath N, Max EE. 1995. Human Ig Sγ regions and their participation in sequential switching to IgE. J. Immunol. 155:3021-36
245. Zhang K, Cheah H-K, Saxon A. 1995. Secondary deletional recombination of rearranged switch region in Ig isotype-switched B cells: a mechanism for isotype stabilization. J. Immunol. 154:2237-47
246. Baskin B, Islam KB, Evengard B, Emtestam L, Smith CIE. 1997. Direct and sequential switching from μ to ε in patients with Schistosoma mansoni infection and atopic dermatitis. Eur. J. Immunol. 27:130-35
247. Jabara HH, Loh R, Rameseser N, Vercelli D, Geha RS. 1993. Sequential switching from μ to ε in human B cells stimulated with IL-4 and hydrocortisone. J. Immunol. 151:4528-33
248. Kinoshita K, Hariga M, Fagarsan S, Muramatsu M, Honjo T. 2001. Hallmark of active class switch recombination: transcripts directed by I exon promoters on looped-out circular DNAs. Proc. Natl. Acad. Sci. USA 98:12620-23
249. Neuberger MS, Ehrenstein MR, Klix N, Jolly CJ, Yé Lelamos J, et al. 1998. Monitoring and interpreting the intrinsic features of somatic hypermutation. Immunol. Rev. 162:107-16
250. Berek C, Milstein C. 1987. Mutational drift and repertoire shift in the maturation of the immune response. Immunol. Rev. 96:23-41
251. Shlomchik MJ, Nemazee DA, van Snick J, Weigert M. 1987. Structure and function of anti-DNA autoantibody-derived from a single autoimmune mouse. Proc. Natl. Acad. Sci. USA 84:9150-54
252. Cook GP, Tomlinson IM. 1995. The human VH repertoire. Immunol. Today 16:237-42
253. Coker H, Durham SR, Gould HJ. 2003. Local somatic hypermutation, class switch recombination and VH5 bias of immunoglobulin epsilon genes in allergic rhinitis. Submitted
254. Snow RE, Chapman CJ, Frew AJ, Holgate ST, Stevenson FK. 1995. Analysis of Ig VH region genes encoding IgE antibodies in splenic B lymphocytes of a patient with asthma. J. Immunol. 154:5576-81
255. Snow RE, Chapman CJ, Frew AJ, Holgate ST, Stevenson FK. 1997. Pattern of usage and somatic hypermutation in the VH5 gene segments of a patient with asthma: implications for IgE. Eur. J. Immunol. 27:162-70
256. Snow RE, Djukanovic R, Stevenson FK. 1999. Analysis of immunoglobulin E VH transcripts in a bronchial biopsy of an asthmatic patient confirms bias towards VH5, and indicates local clonal expansion, somatic mutation and isotype switch events. Immunology 98:646-51
257. Van der Stoep N, van der Linden J, Logtenberg T. 1993. Molecular evolution of the human immunoglobulin E response: high incidence of shared mutations and clonal relatedness among VH5 transcripts from three unrelated patients with atopic dermatitis. J. Exp. Med. 177:99-107
258. Tomlinson IM, Walter G, Jones PT, Dear PH, Sonnhammer ELL, Winter G. 1996. The imprint of somatic hypermutation on the rerpertoire of human germline V genes. J. Mol. Biol. 256:813-17
259. Durham SR, Gould HJ, Harold QA. 1997. IgE regulation in tissues. See Ref. 281, pp. 21-36
260. Smurthwaite L, Walker SN, Wilson DR, Birch DS, Merrett TG, et al. 2001. Persistent IgE synthesis in the nasal mucosa of hayfever patients. Eur. J. Immunol. 31:3422-31
261. Wilson DR, Merrett TG, Varga EM, Smurthwaite L, Gould HJ, et al. 2002. Increases in allergen-specific IgE in BAL after segmental allergen challenge in atopic asthmatics. Am. J. Respir. Crit. Care Med. 165:22-26
262. Durham SR, Gould HJ, Thienes CP, Jacobson MR, Masuyama K, et al. 1997. Expression of ε germline gene transcripts and mRNA for the ε heavy-chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur. J. Immunol. 27:2899-906
263. KleinJan A, Vinke JG, Severinjnen LWFM, Fokkens WJ. 2000. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur. Respir. J. 15:491-97
264. Okudaira H, Ohta K, Ogita T, Miyamato T. 1981. Human IgE antibody-forming cells: radio-resistant and radio-sensitive subpopulations. Int. Arch. Allergy Appl. Immunol. 65:162-67
265. Yanagihara Y, Yui Y, Shida T, Okudaira H, Miyamoto T. 1981. Anti-mite IgE antibody production in vitro by peripheral blood lymphocytes from mite-sensitive atopic patients. Int. Arch. Allergy Appl. Immunol. 66:251-58
266. Fagarasan S, Kinoshita K, Muramatsu M, Ikuta K, Honjo T. 2001. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 413:639-43
267. Macpherson AJ, Lamarre A, McCoy K, Harriman GR, Odermatt B, et al. 2001. IgA production without μ or δ chain expression in developing B cells. Nat. Immunol. 2:625-31
268. Cameron LA, Durham SR, Jacobson MR, Masuyama K, Juliusson S, et al. 1998. Expression of IL-4, C epsilon RNA and I epsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids. J. Allergy Clin. Immunol. 101:330-36
269. Ying S, Humbert M, Meng Q, Pfister R, Menz G, et al. 2001. Local expression of ε germline gene transcripts and RNA for the ε heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma. J. Allergy Clin. Immunol. 107:686-92
270. Humbert M, Menz G, Ying S, Corrigan CJ, Robinson DS, et al. 1999. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol. Today 20:528-33
271. Cameron L, Hamid Q, Wright E, Nakamura Y, Christodolopoulos P, et al. 2000. Local synthesis of ε germline gene transcripts, IL-4 and IL-13 in allergic nasal mucosa after ex vivo allergen exposures. J. Allergy Clin. Immunol. 106:46-52
272. Fujieda S, Diaz-Sanchez D, Saxon A. 1998. Combined nasal challenge with diesel exhaust particles and allergen induces in vivo IgE switching. Am. J. Respir. Cell Mol. Biol. 19:507-12
273. Berek C, Kim H-J. 1997. B-cell activation and development within chronically inflamed synovium in rheumatoid and reactive arthritis. Semin. Immunol. 9:261-68
274. Ludewig B, Odermat B, Landmann S, Hengartner H, Zinkernagel RM. 1998. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J. Exp. Med. 188:1493-501
275. Randen I, Brown D, Thompson KM, Hughes-Jones N, Pascual V, et al. 1992. Clonally related IgM rheumatoid factors undergo affinity maturation in the rheumatoid synovial tissue. J. Immunol. 148:3296-301
276. Dechanet J, Merville P, Durand I, Banchereau J, Miossec P. 1995. The ability of synoviocytes to support terminal differentiation of activated cells may explain plasma cell accumulation in rheumatoid synovium. J. Clin. Invest. 95:456-63
277. Chvatchko Y, Kosco-Vilbois MH, Herren S, Lefort J, Bonnefoy J-Y. 1996. Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge. J. Exp. Med. 184:2353-60
278. Tada T, Okumura K, Platteau B, Beckers A, Bazin H. 1975. Half-lives of two types of rat homocytotropic antibodies in circulation and in the skin. Int. Arch. Allergy Appl. Immunol. 48:116-31
279. Scharenberg AM, Kinet J-P. 1994. Is localized immunoglobulin E synthesis the problem? Curr. Biol. 4:140-42
280. Novak N, Bieber T. 2002. To bend or not to bend. Nat. Immunol. 3:607-8
281. Saphire EO, Parren PWHI, Pantophlet R, Zwick MB, Morris GM, et al. 2001. Crystal structure of a neutralizing human IgG against HIV-1: a template for vaccine design. Science 293:1155-59
282. Harris LJ, McPherson A. 1998. Crystallographic structure of an intact IgG1 monoclonal antibody. J. Mol. Biol. 277:861-72
283. Harris LJ, Larson SB, Hasel KW, McPherson A. 1997. Refined structure of an intact IgG2a monoclonal antibody. Biochemistry 36:1581-97
284. Sondermann P, Kaiser J, Jacob U. 2001. Molecular basis for immune complex recognition: a comparison of Fc-receptor structure. J. Mol. Biol. 309:737-49
285. Paul WE, ed. 1999. Fundamental Immunology. Philadelphia: Lippincott-Raven. 4th ed.
286. Vercelli D, ed. 1997. IgE Regulation. Colchester, UK: Wiley
287. Nola J, Neuberger MS. 2002. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycolase. Nature 418:99-103
288. Rada C, Williams GT, Nilsen H, Barnes DE, Lindahl T, Neuberger MS. 2002. Immunoglobulin isotype switching in inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12:1746-55